Sativa-Dominant Hybrid

Harlequin

Type: Sativa-Dominant Hybrid
Dominant terpene: Myrcene
Found at: 1 listing

Effects

Onset & progression

Gentle, gradual onset; effects begin 5-10 minutes post-inhalation; full experience develops over 15-20 minutes; lacks rapid intensity of high-THC strains

Duration

Primary effects: 2-3 hours inhalation; subtle aftereffects: 1-2 additional hours; gentle comedown without crash or brain fog; no notable morning-after effects even from evening use

Common effects

Mental: clear-headed alertness; subtle mood elevation; lucid state with light euphoria; slightly dreamlike or contemplative without distraction; minimal cognitive impairment; facilitates conversation and creative work. Physical: gentle warm relaxation spreading through body; muscle tension ease without heavy sedation; pain dulling/softening rather than elimination; post-exercise endorphin-like sensation; diffuse comfort. Mood: functional elevation; stress reduction; minimal anxiety or paranoia (CBD counteracts THC anxiety)

Potential adverse effects

Mild headaches in some users (especially CBD-unaccustomed); occasional dizziness at higher doses; mild stimulation may interfere with sleep in sensitive individuals; insufficient for those seeking heavy sedation or intense intoxication

Ideal occasions

Daytime use; creative work; strategic thinking; detailed projects; sustained concentration; social situations requiring composure; business meetings; family gatherings; physical activities (yoga, hiking, cycling, light exercise); post-workout recovery; stress management while remaining functional; morning/midday routines; situations requiring mental clarity with mild relaxation

Not recommended for

Deep sedation or heavy body-load sessions; intense psychoactive experiences; profound consciousness alteration; bedtime use for stimulation-sensitive individuals (avoid 3-4 hours before sleep); heavy physical labor or intense athletics requiring different cannabinoid profiles

Terpenes

Dominant terpenes

Myrcene (dominant - earthy, musky, tropical mango notes); contributes calming properties without heavy sedation

Secondary terpenes

Pinene (alpha and beta - fresh pine, Christmas tree notes); Beta-caryophyllene (spicy, peppery, woody accents); Trace amounts: humulene; phellandrene; alpha-bisabolol. Overall profile: understated, musky earth transitioning to sweet tropical fruit with herbal-spicy exhale

Cannabinoid profile

CBD: 6-15% (commonly 7-10%); THC: 7-15% (commonly 4-7%); typical ratio 5:2 CBD-to-THC; some phenotypes approach 1:1 ratio. Newer phenotypes claim 20%+ CBD with sub-1% THC (hemp-compliant). CBG and CBC present in trace amounts. Balanced profile provides entourage effect with gentle psychoactivity; CBD modulates THC's anxiety-inducing potential. Moderate THC allows functional use; substantial CBD offers therapeutic relief without impairment

Lineage

Lineage & origins

Developed in Northern California in the early 2000s by Mr. Green of House of David Collective. Created from four landrace genetics: Colombian Gold (1970s phenotype), Thai sativa from regions near Laos, Swiss landrace sativa, and Nepali indica from Mustang State. Originally bred for hash production but surprised breeders with high CBD expression. Pioneering high-CBD strain in U.S. medical cannabis movement.

Genetics & phenotypes

Clone-only strain with reliable 5:2 CBD-to-THC ratio expression. Early phenotypes tested 7-10% CBD and 4-7% THC; newer selections claim 20%+ CBD. Consistent genetic stability compared to many hybrids. Dense medium-sized buds with medium-green leaves; orange-to-vivid-red pistils; thick trichome coverage despite moderate THC. Phenotypic variations exist but maintain core characteristics. True genetics never officially released in seed form; feminized seeds from various sources vary in authenticity.

Comparable strains

ACDC (20:1 CBD-to-THC, more sedating, higher CBD percentage); Cannatonic (1:1 ratios available, slightly more psychoactive, sweeter pine flavor); Harle-Tsu (18-21% CBD, more indica influence, woody tea-like flavor, Harlequin offspring); Ringo's Gift (variable 1:1 to 24:1 ratios, spicy hash and mint flavors, Harlequin descendant); Sour Tsunami (diesel aroma, myrcene-terpinolene dominant, pioneering CBD strain)

Growing

Flowering time

8-10 weeks; most phenotypes finish around 9 weeks; harvest timing impacts CBD-to-THC ratio (earlier harvest ~8 weeks preserves higher CBD; extended flowering shifts toward THC); trichome monitoring essential (target mostly cloudy with 10-20% amber)

Plant structure

Medium to tall height; lateral branching; elongated flowering (sativa-dominant pattern); dense, resinous, sticky buds requiring structural support during final flowering weeks; typical sativa shape - bushy with strong lateral branching when managed; requires vertical space indoors or training techniques

Resilience

Moderate resilience to pests and environmental stress; not particularly hardy compared to pure landrace genetics; susceptible to botrytis and powdery mildew in humid conditions; requires humidity management and good airflow; responds well to preventative pest management; adapts to both soil and hydroponic cultivation

Yield potential

Indoor: 350-700g/mÂ² (12-25 oz/mÂ²) depending on phenotype and methods; Outdoor: 21-25 oz per plant in appropriate climates; generous yields with proper care; training techniques (SCROG, topping, LST) increase yield potential

Quality indicators

Dense structure; generous trichome coverage (thick crystalline coating); medium-green coloration; orange-to-red pistils; prominent aromatic expression (musky earth to tropical fruit); proper 2-4 week cure enhances terpene preservation and smoothness; sticky, resinous texture

Cannabinoid and terpene profiles vary significantly by cultivator, growing conditions, harvest timing, and curing methods. Information represents general patterns and should not be interpreted as guaranteed specifications. Individual responses vary based on personal biochemistry, tolerance, consumption method, and dosage. Effects described reflect commonly reported experiences but may not apply universally. For medical applications, consult qualified healthcare providers. This information is for educational purposes and does not constitute medical advice. Request laboratory testing results (COAs) when available for accurate batch-specific cannabinoid percentages, terpene profiles, and contaminant testing.